• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

"Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news.

作者信息

Giovanella Luca, Verburg Frederik A, Ovčariček Petra Petranović, Iakovou Ioannis, Mihailovic Jasna, Vrachimis Alexis, Zerdoud Slimane, Hoffmann Martha, Luster Markus

机构信息

EANM Thyroid Committee, Vienna, Austria.

Clinic for Nuclear Medicine and Thyroid Centre, Imaging Institute of Southern Switzerland, Ospedale San Giovanni, Via Ospedale 6, 6500, Bellinzona, Switzerland.

出版信息

Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1342-1344. doi: 10.1007/s00259-020-04748-4.

DOI:10.1007/s00259-020-04748-4
PMID:32157430
Abstract
摘要

相似文献

1
"Quid autem vides festucam in oculo fratris tui et trabem in oculo tuo non vide" on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news.“你为何只看见你弟兄眼中的刺，却不想自己眼中有梁木呢”：关于放射性碘时代甲状腺功能亢进症所致死亡率及抗甲状腺药物所致副作用的虚假新闻。
Eur J Nucl Med Mol Imaging. 2020 Jun;47(6):1342-1344. doi: 10.1007/s00259-020-04748-4.
2
COMBINATION OF RADIOIODINE 131 I AND ANTITHYROID DRUGS IN THE TREATMENT OF HYPERTHYROIDISM.放射性碘131I与抗甲状腺药物联合治疗甲状腺功能亢进症
Minerva Nucl. 1964 Mar-Apr;8:102-5.
3
Clinical and biochemical changes following 131I therapy for hyperthyroidism in patients not pretreated with antithyroid drugs.未预先使用抗甲状腺药物治疗的甲亢患者接受¹³¹I治疗后的临床和生化变化。
Neth J Med. 1999 Nov;55(5):215-21. doi: 10.1016/s0300-2977(99)00066-2.
4
The treatment of hyperthyroidism with iodine-131.用碘-131治疗甲状腺功能亢进症。
Semin Nucl Med. 1978 Jan;8(1):95-103. doi: 10.1016/s0001-2998(78)80010-5.
5
[EFFECT OF THYREOVALUN, AN ANTITHYROID DRUG OF PLANT ORIGIN, ON THE THYROID RADIOIODINE (I-131) INCORPORATION TEST].[植物源抗甲状腺药物甲状腺素对甲状腺放射性碘（I - 131）摄取试验的影响]
Arztl Forsch. 1965 Mar 10;19:155-7.
6
Is long-term methimazole therapy as effective as radioiodine for treating hyperthyroidism?长期服用甲巯咪唑治疗甲亢与放射性碘治疗相比，效果是否相同？
Nat Clin Pract Endocrinol Metab. 2005 Nov;1(1):14-5. doi: 10.1038/ncpendmet0019.
7
Fractionated radioiodine therapy for hyperthyroidism caused by widespread metastatic follicular thyroid carcinoma.分次放射性碘治疗广泛转移性滤泡状甲状腺癌所致的甲状腺功能亢进症。
Thyroid. 2010 May;20(5):569-70. doi: 10.1089/thy.2009.0460.
8
Radioiodine therapy for hyperthyroidism.放射性碘治疗甲状腺功能亢进症。
Drug Ther Bull. 2006 Jun;44(6):44-8. doi: 10.1136/dtb.2006.44644.
9
[Treatment of hyperthyroidism with 131 I].[用131碘治疗甲状腺功能亢进症]
Rev Esp Med Nucl. 2003 Jul-Aug;22(4):262-76; quiz 277-81. doi: 10.1016/s0212-6982(03)72199-5.
10
Prevalence of inappropriate drug treatment in patients with hyperthyroidism.甲状腺功能亢进症患者不适当药物治疗的患病率。
Br Med J (Clin Res Ed). 1985 Nov 23;291(6507):1491-2. doi: 10.1136/bmj.291.6507.1491.

本文引用的文献

1
Methimazole and risk of acute pancreatitis.甲巯咪唑与急性胰腺炎风险
Lancet Diabetes Endocrinol. 2020 Mar;8(3):187-189. doi: 10.1016/S2213-8587(20)30025-5. Epub 2020 Feb 5.
2
Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts.Graves 病和毒性结节性甲状腺肿，由甲状腺功能亢进持续时间加重，与阿尔茨海默病和血管性痴呆有关：基于登记的两个大型队列的长期随访。
Thyroid. 2020 May;30(5):672-680. doi: 10.1089/thy.2019.0672. Epub 2020 Mar 3.
3
Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Cohort Study.
放射性碘治疗甲状腺功能亢进后癌症风险：一项队列研究。
Thyroid. 2020 Feb;30(2):243-250. doi: 10.1089/thy.2019.0205. Epub 2020 Jan 23.
4
Association of Radioactive Iodine Treatment of Hyperthyroidism With Cancer Mortality: An Unjustified Warning?放射性碘治疗甲状腺功能亢进症与癌症死亡率的关联：一个不合理的警告？
J Clin Endocrinol Metab. 2020 Apr 1;105(4). doi: 10.1210/clinem/dgz305.
5
Errare humanum est, sed in errare perseverare diabolicum: methodological errors in the assessment of the relationship between I-131 therapy and possible increases in the incidence of malignancies.人孰无过，但坚持错误则属恶魔行径：¹³¹I治疗与恶性肿瘤发病率可能增加之间关系评估中的方法学错误。
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):519-522. doi: 10.1007/s00259-019-04580-5.
6
Joint statement from the Society for Endocrinology and the British Thyroid Association regarding 'Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism'.内分泌学会和英国甲状腺协会关于“放射性碘治疗与甲状腺功能亢进症患者癌症死亡率的关联”的联合声明。
Clin Endocrinol (Oxf). 2020 Mar;92(3):266-267. doi: 10.1111/cen.14136. Epub 2019 Dec 13.
7
There Is No Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism.放射性碘治疗与甲状腺功能亢进症患者的癌症死亡率无关。
J Nucl Med. 2019 Nov;60(11):1500-1501. doi: 10.2967/jnumed.119.235929. Epub 2019 Oct 4.
8
Spotlight on the Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism is Keeping the Highest Risk From Antithyroid Drugs in the Blind Spot.放射性碘治疗与甲状腺功能亢进症患者癌症死亡率的关联备受关注，抗甲状腺药物的最高风险被忽视。
Clin Nucl Med. 2019 Oct;44(10):789-791. doi: 10.1097/RLU.0000000000002792.
9
Use of anti-thyroid drugs in patients with hyperthyroidism: a case for shared decision-making.抗甲状腺药物在甲状腺功能亢进症患者中的应用：共同决策的案例
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2408-2409. doi: 10.1007/s00259-019-04476-4. Epub 2019 Aug 9.
10
Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism.放射性碘治疗与甲状腺功能亢进症患者癌症死亡率的关联。
JAMA Intern Med. 2019 Aug 1;179(8):1034-1042. doi: 10.1001/jamainternmed.2019.0981.